Time is penumbra: Imaging, selection and outcome: The Johann Jacob Wepfer Award 2014

Cerebrovascular Diseases

Volumn 38, Issue 1, 2014, Pages 59-72

  Davis, Stephen ^a   Donnan, Geoffrey A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical trials; Ischaemia; Johann Jacob Wepfer; Penumbra; Reperfusion; Stroke

Indexed keywords

DESMOTEPLASE; PLACEBO; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; BLOOD FLOW; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; FIBRINOLYTIC THERAPY; HUMAN; IN VIVO STUDY; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION; REVIEW; SCINTIGRAPHY; THROMBECTOMY DEVICE; ANIMAL; AWARDS AND PRIZES; BRAIN ISCHEMIA; COMPLICATION; STROKE; TIME; TREATMENT OUTCOME;

ANIMALS; AWARDS AND PRIZES; BRAIN ISCHEMIA; FIBRINOLYTIC AGENTS; HUMANS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84908602638     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000365503     Document Type: Review

References (76)

1. Symon L: The ischaemic penumbra: The beginning; in Donnan GA, Baron JC, Davis SM, Sharp FR (eds): The Ischemic Penumbra. New York, Informa Healthcare, 2007, pp 1-6.
2. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia - The ischemic penumbra. Stroke 1981; 12: 723-725.
3. Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P: Reversal of focal 'misery- perfusion syndrome' by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke 1981; 12: 454- 459.
4. Wise RJ, Bernardi S, Frackowiak RS, Legg NJ, Jones T: Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain 1983; 106: 197-222.
5. Marchal G, Serrati C, Rioux P, Petit-Taboue MC, Viader F, de la Sayette V, Le Doze F, Lochon P, Derlon JM, Orgogozo JM, et al: PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet 1993; 341: 925-927.
6. Marchal G, Furlan M, Beaudouin V, Rioux P, Hauttement JL, Serrati C, de la Sayette V, Le Doze F, Viader F, Derlon JM, Baron JC: Early spontaneous hyperperfusion after stroke. A marker of favourable tissue outcome? Brain 1996; 119: 409-419.
7. Sharp FR, Xu H, Liu X, Ran R: Molecular biology of the penumbra; in Donnan G, Baron JC, Davis SM, Sharp FR (eds): The Ischemic Penumbra. New York, Informa Healthcare, 2007, pp 93-107.
8. Donnan GA, Davis SM: Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy. Lancet Neurol 2002; 1: 417-425.
9. Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G: Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001; 124: 20-29.
10. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan GF, Scott AM, Bladin CF, McKay WJ, Donnan GA: Identifying hypoxic tissue after acute ischemic stroke using PET and 18 F-fluoromisonidazole. Neurology 1998; 51: 1617- 1621.
11. Read SJ, Hirano T, Abbott DF, Markus R, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan GF, Scott AM, Bladin CF, McKay WJ, Donnan GA: The fate of hypoxic tissue on 18 F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol 2000; 48: 228-235.
12. Spratt NJ, Donnan GA, Howells DW: Characterisation of the timing of binding of the hypoxia tracer FMISO after stroke. Brain Res 2009; 1288: 135-142.
13. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S: Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 2005; 36: 1700-1704.
14. Campbell BC, Weir L, Desmond PM, Tu HT, Hand PJ, Yan B, Donnan GA, Parsons MW, Davis SM: CT perfusion improves diagnostic accuracy and confidence in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2013; 84: 613-618.
15. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, Parsons MW: Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke 2012; 43: 2648-2653.
16. Ang TE, Levi C, Ma HH, et al: Multimodal CT in acute stroke: should we wait for a serum creatinine before giving IV contrast? No! Int J Stroke 2014; 9(suppl 1):24.
17. Baird AE, Austin MC, McKay WJ, Donnan GA: Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome. J Neurol Neurosurg Psychiatry 1996; 61: 26-29.
18. Davis SM, Chua MG, Lichtenstein M, Rossiter SC, Binns D, Hopper JL: Cerebral hypoperfusion in stroke prognosis and brain recovery. Stroke 1993; 24: 1691-1696.
19. Barber PA, Davis SM, Infeld B, Baird AE, Donnan GA, Jolley D, Lichtenstein M: Spontaneous reperfusion after ischemic stroke is associated with improved outcome. Stroke 1998; 29: 2522-2528.
20. Infeld B, Davis SM, Donnan GA, Yasaka M, Lichtenstein M, Mitchell PJ, Fitt GJ: Nimodipine and perfusion changes after stroke. Stroke 1999; 30: 1417-1423.
21. Lassen NA: The luxury-perfusion syndrome and its possible relation to acute metabolic acidosis localized within the brain. Lancet 1966; 288: 1113-1115.
22. Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM: Pathophysiological topography of acute ischemia by combined diffusionweighted and perfusion MRI. Stroke 1999; 30: 2043-2052.
23. Heiss WD, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, Wienhard K: Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992; 12: 193-203.
24. Markus R, Reutens DC, Kazui S, Read S, Wright P, Pearce DC, Tochon-Danguy HJ, Sachinidis JI, Donnan GA: Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 2004; 127: 1427-1436.
25. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM; EPITHET Investigators: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7: 299-309.
26. Nagakane Y, Christensen S, Brekenfeld C, Ma H, Churilov L, Parsons MW, Levi CR, Butcher KS, Peeters A, Barber PA, Bladin CF, De Silva DA, Fink J, Kimber TE, Schultz DW, Muir KW, Tress BM, Desmond PM, Davis SM, Donnan GA: EPITHET: positive result after reanalysis using baseline diffusionweighted imaging/perfusion-weighted imaging co-registration. Stroke 2011; 42: 59-64.
27. Ogata T, Christensen S, Nagakane Y, Ma H, Campbell BC, Churilov L, Lansberg MG, Straka M, De Silva DA, Mlynash M, Bammer R, Olivot JM, Desmond PM, Albers GW, Davis SM, Donnan GA; EPITHET and DEFUSE Investigators: The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study. Stroke 2013; 44: 87-93.
28. Ma H, Wright P, Allport L, Phan TG, Churilov L, Ly J, Zavala JA, Arakawa S, Campbell B, Davis SM, Donnan GA: Salvage of the PWI/DWI mismatch up to 48 h from stroke onset leads to favorable clinical outcome. Int J Stroke 2014, Epub ahead of print.
29. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, Wilder MJ, Lutsep HL, Czartoski TJ, Bernstein RA, Chang CW, Warach S, Fazekas F, Inoue M, Tipirneni A, Hamilton SA, Zaharchuk G, Marks MP, Bammer R, Albers GW; DEFUSE 2 Study Investigators: MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012; 11: 860-867.
30. Ma H, Zavala JA, Teoh H, Churilov L, Gunawan M, Ly J, Wright P, Phan T, Arakawa S, Davis SM, Donnan GA: Fragmentation of the classical magnetic resonance mismatch 'penumbral' pattern with time. Stroke 2009; 40: 3752-3757.
31. Touzani O, Baron JC: Duration and thresholds of the ischemic penumbra in different species; in Donnan G, Baron JC, Davis SM, Sharp FR (eds): The Ischemic Penumbra. New York, Informa Healthcare, 2007, pp 37-57.
32. Falcao AL, Reutens DC, Markus R, Koga M, Read SJ, Tochon-Danguy H, Sachinidis J, Howells DW, Donnan GA: The resistance to ischemia of white and gray matter after stroke. Ann Neurol 2004; 56: 695-701.
33. Koga M, Reutens DC, Wright P, Phan T, Markus R, Pedreira B, Fitt G, Lim I, Donnan GA: The existence and evolution of diffusionperfusion mismatched tissue in white and gray matter after acute stroke. Stroke 2005; 36: 2132-2137.
34. Christensen S, Campbell BCV, Perez de la Ossa N, Lansberg MG, Straka M, De Silva DA, Nagakane Y, Ogata T, Mlynash M, Bammer R, Olivot JM, Desmond PM, Albers GW, Donnan GA, Davis SM: Optimal perfusion thresholds for prediction of tissue destined for infarction in the combined EPITHET and DEFUSE dataset. Stroke 2010; 41:e297.
35. Churilov L, Liu D, Ma H, Christensen S, Nagakane Y, Campbell B, Parsons MW, Levi CR, Davis SM, Donnan GA: Multiattribute selection of acute stroke imaging software platform for Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) clinical trial. Int J Stroke 2013; 8: 204-210.
36. Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM; EPITHET-DEFUSE Investigators: The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012; 32: 50-56.
37. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, Parsons MW: Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011; 42: 3435-3440.
38. NINDS: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
39. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375: 1695-1703.
40. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, Donnan GA, Tress BM, Davis SM: Prediction of stroke outcome with echoplanar perfusion- And diffusionweighted MRI. Neurology 1998; 51: 418-426.
41. Barber PA, Davis SM, Darby DG, Desmond PM, Gerraty RP, Yang Q, Jolley D, Donnan GA, Tress BM: Absent middle cerebral artery flow predicts the presence and evolution of the ischemic penumbra. Neurology 1999; 52: 1125-1132.
42. Parsons MW, Miteff F, Bateman GA, Spratt N, Loiselle A, Attia J, Levi CR: Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology 2009; 72: 915-921.
43. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, O'Brien B, Bladin C, McElduff P, Allen C, Bateman G, Donnan G, Davis S, Levi C: A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med 2012; 366: 1099-1107.
44. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebocontrolled randomised trial. Lancet Neurol 2008; 7: 299-309.
45. Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM: Diffusion- And perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 2002; 51: 28-37.
46. Ma H, Parsons MW, Christensen S, Campbell BCV, Churilov L, Connelly A, Yan B, Bladin C, Phan TG, Barber PA, Read S, Hankey GJ, Markus R, Wijeratne T, Grimley R, Mahant N, Kleinig T, Sturm J, Lee A, Blacker D, Gerraty R, Krause M, Desmond PM, Carey L, Howells DW, Davis SM, Donnan GA: A multicentre, randomized, double blinded, placebo controlled phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke 2012; 7: 74-80.
47. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP; DEFUSE Investigators: Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006; 60: 508-517.
48. Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR: Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000; 47: 462-469.
49. Chemmanam T, Campbell BCV, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM: Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch. Neurology 2010; 75: 1040- 1047.
50. Campbell BCV, Purushotham A, Christensen S, Desmond P, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM: The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab 2012; 32: 50-56.
51. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Bammer R, Marks MP, Albers GW: Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40: 469-475.
52. Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, Ebinger M, Barber PA, Bladin C, Donnan GA, Davis SM: Pretreatment diffusion- And perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30: 1214-1225.
53. Campbell BCV, Christensen S, Butcher KS, Gordon I, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, De Silva DA, Donnan GA, Davis SM: Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010; 41: 82-88.
54. Campbell BCV, Christensen S, Foster SJ, Desmond PM, Parsons MW, Butcher KS, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM: Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis. Cerebrovasc Dis 2010; 29: 592- 596.
55. Straka M, Albers GW, Bammer R: Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010; 32: 1024-1037.
56. Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, Campbell BC, Bammer R, Olivot JM, Desmond P, Davis SM, Donnan GA, Albers GW: RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Stroke 2011; 42: 1608-1614.
57. Campbell BCV, Tu HT, Christensen S, Desmond PM, Levi CR, Bladin CF, Hjort N, Ashkanian M, Solling C, Donnan GA, Davis SM, Ostergaard L, Parsons MW: Assessing response to stroke thrombolysis: validation of 24 hour multimodal magnetic resonance imaging. Arch Neurol 2012; 69: 46-50.
58. Ebinger M, Christensen S, De Silva DA, Parsons MW, Levi CR, Butcher KS, Bladin CF, Barber PA, Donnan GA, Davis SM: Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke 2009; 40: 1353-1358.
59. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, Sohngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S: Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-150.
60. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W: Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006; 37: 1227-1231.
61. Mishra NK, Albers GW, Davis SM, Donnan GA, Furlan AJ, Hacke W, Lees KR: Mismatchbased delayed thrombolysis: a meta-analysis. Stroke 2010; 41:e25-e33.
62. Picanco MR, Christensen S, Campbell BC, Churilov L, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM: Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes. Int J Stroke 2014; 9: 266-269.
63. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA: Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903.
64. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL: A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013; 368: 914-923.
65. Ciccone A, Valvassori L; SYNTHESIS Expansion Investigators: Endovascular treatment for acute ischemic stroke. N Engl J Med 2013; 368: 2433-2434.
66. Baker WL, Colby JA, Tongbram V, Talati R, Silverman IE, White CM, Kluger J, Coleman CI: Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med 2011; 154: 243- 252.
67. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO; SWIFT Trialists: Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249.
68. Albers G, Straka M, Kemp S, Mlynash M, Jovin T, Wechsler L, Wilder M, Lutsep H, Keogh B, Bernstein R, Chang C, Warach S, Fazekas F, Thai D, Inoue M, Tipirneni A, Hamilton S, Zaharchuk G, Marks M, Bammer R, Lansberg MG: Results of DEFUSE 2: imaging endpoints. Stroke 2012; 43:A52.
69. Campbell BC, Mitchell PJ, Yan B, Parsons MW, Christensen S, Churilov L, Dowling RJ, Dewey H, Brooks M, Miteff F, Levi C, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Kleinig T, Scroop R, Chryssidis S, Barber A, Hope A, Moriarty M, McGuinness B, Wong AA, Coulthard A, Wijeratne T, Lee A, Jannes J, Leyden J, Phan TG, Chong W, Holt ME, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM: A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND- IA). Int J Stroke 2014; 9: 126-132.
70. Donnan GA, Baron JC, Davis SM, Sharp FR (eds): The Ischaemic Penumbra. New York, Informa Healthcare, 2007, pp 7-20.
71. Heiss WD, Graf R: The ischemic penumbra. Curr Opin Neurol 1994; 7: 11-19.
72. Kinouchi H, Sharp FR, Koistinaho J, Hicks K, Kamii H, Chan PH: Induction of heat shock hsp70 mRNA and HSP70 kDa protein in neurons in the 'penumbra' following focal cerebral ischemia in the rat. Brain Res 1993; 619: 334-338.
73. Hossmann KA: Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-565.
74. Hakim AM: The cerebral ischemic penumbra. Can J Neurol Sci 1987; 14: 557-559.
75. Baron JC: Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999; 9: 193-201.
76. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S; DIAS Study Group: The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36: 66-73.